House Commerce Committee expected to release FDA reform bill by early July.
This article was originally published in The Tan Sheet
HOUSE COMMERCE COMMITTEE FDA REFORM BILL EXPECTED BY EARLY JULY, using Oversight & Investigations Subcommittee ranking minority member Rep. Ron Wyden's (D-Ore.) "FDA Modernization Act" (HR 1742) as a basis for discussion. Introduced June 6, HR 1742 reflects agreement on both the left and right of the political spectrum on the need for such FDA reforms as increased use of expert panels to speed review of certain drugs; use of independent testing organizations; fewer restrictions on export of U.S.-made products; and separate requirements for approval of drugs and biologics.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC